Is pancreaticodoudenectomy with vascular resection a safe procedure in developing country? Early outcomes and review of national literature

Dar, Faisal Saud; Bhatti, Abu Bakar Hafeez; Dogar, Abdul Wahab; Zia, Haseeb; Ulhaq, Ihsan; Rana, Atif; Khan, Nasir; Liaqat, Amna; Salih, Muhammad; Shah, Najmul Hassan

doi:10.1016/j.ijsu.2015.06.073

Cited by 5 publications

(8 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In total six studies from Pakistan report pancreatic tumor stage. As per the data from these studies, the majority (53%) were stage 3 and 4 tumors (5,19,22,24,28,29).…”

Section: Tumor Gradementioning

confidence: 67%

See 2 more Smart Citations

Pancreatic Cancers: A Review of Studies from Pakistan and Comparison with Global Trends

Adnan

Ali

2021

PJPH

View full text Add to dashboard Cite

The objective of this review article is to discuss clinical data from studies on Pakistani pancreatic cancer population and its comparison with international data. This review article will allow researchers to identify gaps in the data and hence to design further research in order to address these gaps accordingly. Search was carried out via Google Scholar, PubMed and PakMediNet search engines using keywords “Pancreatic cancers”, “Pancreatic adenocarcinoma” and “Pakistan”. Pancreatic cancers are one of the most lethal cancers globally. Statistics show that 97.8% of cases of pancreatic cancers in Pakistan have led to mortality. For various cancers around the world, epidemiological data has been used for development of diagnostic tools and therapies. Despite the alarming situation of pancreatic cancers in Pakistan, only limited work has been done in this area. Majority of the studies are based exclusively on reporting of clinical data. Pakistan has not been able to even gather sufficient data to proceed research based on association of molecular aspects of tumor with clinical characteristics. On the contrary, researchers, scientists and clinicians from other parts of the world are already working on association studies, prediction of prognosis, treatment selection and improving the survival of their population. It is an immense need of the situation that molecular based studies are carried out on Pakistani pancreatic cancer population so that diagnosis, prognosis, treatment and survival of these patients can be made better.

show abstract

“…In total six studies from Pakistan report pancreatic tumor stage. As per the data from these studies, the majority (53%) were stage 3 and 4 tumors (5,19,22,24,28,29).…”

Section: Tumor Gradementioning

confidence: 67%

“…Four investigations included lymph node invasion status in their study. 49.4% patients were found with positive lymph node invasion (5,19,28,29).…”

Section: Lymph Node Invasionmentioning

confidence: 99%

See 1 more Smart Citation

Pancreatic Cancers: A Review of Studies from Pakistan and Comparison with Global Trends

Adnan

Ali

2021

PJPH

View full text Add to dashboard Cite

show abstract

“…All patients included in the study had good functional status (Eastern cooperative oncology group 0 and 1) and underwent plastic stent placement. Details pertinent to patient selection, operative procedure, and post operative care have been detailed elsewhere [10,11].…”

Section: Methodsmentioning

confidence: 99%

“…Details pertinent to patient selection, operative procedure, and postoperative care have been detailed elsewhere. 10,11…”

Section: Methodsmentioning

confidence: 99%

Preoperative Endoscopic Biliary Stenting Before Pancreaticoduodenectomy: Does Timing Matter?

Bhatti

Jafri

Khan³

et al. 2020

Surg Innov

Self Cite

View full text Add to dashboard Cite

Background. The role of preoperative biliary stenting (PBS) before pancreaticoduodenectomy (PD) in patients with obstructive jaundice is debatable. The objective of the current study was to assess PD outcomes after upfront surgery or PBS and determine the impact of stent to surgery duration on PD outcomes. Methods. We reviewed patients who underwent PD between 2011 and 2019. Patients were grouped based on whether they underwent upfront surgery (n = 67) or PBS (n = 66). We further assessed outcomes based on stent to surgery duration. Results. There was no significant difference in 30-day mortality (3% vs. 2.9%, P = 1), 90-day mortality (7.5% vs. 4.4%, P = .4), and Grade B-C pancreatic fistula rates (7.5% vs. 4.4%, P = .4) in the PBS and upfront surgery groups, respectively. A significant increase in wound infections (22.7% vs. 7.4%, P = .01) and readmissions (10.6% vs. 0, P = .006) was seen in the PBS group. The highest rate of wound infection was seen when stent to surgery duration was 4-6 weeks (41.6%). The wound infection rates in the upfront surgery group, high-risk PBS group (4-6 weeks), and low-risk PBS group were 5/67(7.4%), 5/12(41.6%), and 7/36(19.4%), respectively ( P = .008). Conclusions. PBS increases postoperative wound infections when compared with upfront surgery. Patients operated between 4 and 6 weeks after stenting have the highest rate of wound infection.

show abstract

Extended pancreatectomy as defined by the ISGPS: useful in selected cases of pancreatic cancer but invaluable in other complex pancreatic tumors

Mitra

Pai

Dusane

et al. 2018

Langenbecks Arch Surg

View full text Add to dashboard Cite

show abstract

Is pancreaticodoudenectomy with vascular resection a safe procedure in developing country? Early outcomes and review of national literature

Abstract: In developing countries, extended lymphadenectomy with vascular resection can be safely performed with pancreaticoduodenectomy in specialized hepatobiliary units.

Cited by 5 publications

References 21 publications

Pancreatic Cancers: A Review of Studies from Pakistan and Comparison with Global Trends

Pancreatic Cancers: A Review of Studies from Pakistan and Comparison with Global Trends

Preoperative Endoscopic Biliary Stenting Before Pancreaticoduodenectomy: Does Timing Matter?

Extended pancreatectomy as defined by the ISGPS: useful in selected cases of pancreatic cancer but invaluable in other complex pancreatic tumors

Contact Info

Product

Resources

About